Malaria Drug Resistance and Disease Virulence

$1,080,355ZIAFY2012AINIH

National Institute Of Allergy And Infectious Diseases

Investigators

Linked publications & trials

Paper 38971776 Paper 37314336 Paper 37236355 Paper 36910690 Paper 36864926 Paper 36625569 Paper 35651694 Paper 35618711 Paper 35210361 Paper 34090438 Paper 34044591 Paper 33824913 Paper 33731432 Paper 33653959 Paper 32817236 Paper 32730249 Paper 32586776 Paper 32404110 Paper 32365102 Paper 31366610 Paper 31221627 Paper 30872477 Paper 30580023 Paper 30572920 Paper 30455312 Paper 30367653 Paper 29846536 Paper 29844160 Paper 29739900 Paper 29723510 Paper 29463530 Paper 29394891 Paper 28988930 Paper 28934434 Paper 27531718 Paper 26888201 Paper 26738565 Paper 25890383 Paper 25825251 Paper 25781890 Paper 25201310 Paper 25081932 Paper 24876390 Paper 24291603 Paper 23562882 Paper 23448727 Paper 23389616 Paper 23305874 Paper 23162138 Paper 22855752 Paper 22724026 Paper 22531353 Paper 22393475 Paper 22270182 Paper 22232453 Paper 22023447 Paper 21992120 Paper 21860664 Paper 21817045 Paper 21786288 Paper 21463505 Paper 21300016 Paper 20595466 Paper 20101240 Paper 19884511 Paper 19734910 Paper 19729847 Paper 19428659 Paper 18192399 Paper 17572690 Paper 17402683 Paper 16987557 Paper 16794577 Paper 16567953 Paper 16183150 Paper 15983925 Paper 15973412 Paper 15883156 Paper 15866739 Paper 15827277 Paper 15755424 Paper 15731014 Paper 15701812 Paper 15307435 Paper 15099817 Paper 14697197 Paper 14561790 Paper 12832422 Paper 12480691 Paper 12364789 Paper 11528468 Paper 11517439 Paper 11463110 Paper 11223128 Paper 11160909 Paper 11069183 Paper 11001883 Paper 10826985 Paper 10613703

Abstract

Our research project focuses on how malaria parasites become resistant to major antimalarial drugs and why strains of the two species responsible most human malaria disability and death (Plasmodium falciparum and Plasmodium vivax) show different infectivities to humans and other primates. In these areas of research, we seek advances that can improve the knowledge of disease processes in malaria and thereby support the development or testing of new antimalarial chemotherapies, diagnostic tools, and vaccines. The research activities in our program are multidisciplinary and include field studies in malarious regions of Africa, Asia and South America, as well as programs of basic laboratory investigation.

View original record on NIH RePORTER →